Portfolio company
Indi Molecular
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This life sciences company develops synthetic peptide molecules for use in oncology therapies and diagnostics by pharmaceutical and biotechnology researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ribbon Bio
This company produces synthetic DNA molecules for research and development customers in the biotechnology and biopharmaceutical sectors.
Think Bioscience
This company develops small-molecule therapeutics for pharmaceutical researchers by using synthetic biology and engineered microbes to target difficult-to-drug proteins.
Delta Life Science
This company develops photonic biosensing platforms for label-free biomolecular analysis for use by pharmaceutical scientists and academic researchers.
AgenDx Biosciences
This company develops a molecular diagnostics platform to provide cost-effective cancer and infectious disease testing for clinical settings and healthcare providers.
Biomolex
This company develops digital autoradiography and molecular imaging systems for researchers performing genomic and proteomic analysis in drug discovery and precision medicine.
BioMoti
This company develops targeted drug delivery technology for cancer therapeutics, primarily serving the pharmaceutical and biotechnology industries.
Full-Life Technologies
This company develops radiopharmaceuticals and radionuclide drug conjugates to treat cancer patients through targeted alpha therapy.
Modifi Bio
This biotechnology company develops small molecules that target DNA repair defects to treat brain tumours and other cancers for healthcare providers.
